Abstract: Systems, apparatuses, and methods for providing non-transcranial electrical stimuli to a biological subject may employ a support structure, at least one waveform generator, and at least a first electrode and a second electrode. The system can be sized and dimensioned to be worn on a head of the biological subject and operable to deliver non-transcranial electrical stimuli to at least one of the temporomandibular joints of the biological subject.

Abstract: Systems, apparatuses, and methods for providing non-transcranial electrical stimuli to a biological subject may employ a support structure, at least one waveform generator, and at least a first electrode and a second electrode. The system can be sized and dimensioned to be worn on a head of the biological subject and operable to deliver non-transcranial electrical stimuli to at least one of the temporomandibular joints of the biological subject.

Abstract: Systems, apparatuses, and methods for providing non-transcranial electrical stimuli to a biological subject may employ a support structure, at least one waveform generator, and at least a first electrode and a second electrode. The system can be sized and dimensioned to be worn on a head of the biological subject and operable to deliver non-transcranial electrical stimuli to at least one of the temporomandibular joints of the biological subject.

Abstract: Systems, apparatuses, and methods for providing non-transcranial electrical stimuli to a biological subject may employ a support structure, at least one waveform generator, and at least a first electrode and a second electrode. The system can be sized and dimensioned to be worn on a head of the biological subject and operable to deliver non-transcranial electrical stimuli to at least one of the temporomandibular joints of the biological subject.

Abstract: The present invention is generally directed to the integration of cytoskeletal manipulation with genetic and proteomic analysis. “Cytoskeletal manipulation” references any technology that uses either cytoskeletal integrity or cell adhesion to isolate symptomatic cells from asymptomatic cells as a gatekeeping step for genetic and proteomic analysis. As used in the present invention, the term “isolate” means separating symptomatic from asymptomatic cells based on the cells' demonstration of the relevant associated intracellular or intercellular architectural properties. The further analysis of cells sorted using this invention may include any advanced form of chemical, physical, or biological testing including all forms of genetic and protein analysis, or alternative form of biological expression analysis that is now known or might in the future be developed.